Palshof, J A, Høgdall, E V S, Poulsen, T S, Linnemann, D, Jensen, B V, Pfeiffer, P, Tarpgaard, L S, Brünner, N, Stenvang, J, Yilmaz, M & Nielsen, D L 2017, ' Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer ', BMC Cancer, vol. 17, no. 1, 48 . https://doi.org/10.1186/s12885-016-3001-y BMC Cancer Palshof, J A, Høgdall, E V S, Poulsen, T S, Linnemann, D, Jensen, B V, Pfeiffer, P, Tarpgaard, L S, Brunner, N, Stenvang, J, Yilmaz, M & Nielsen, D L 2017, ' Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer ', BMC Cancer, vol. 17, 48 . https://doi.org/10.1186/s12885-016-3001-y Palshof, J A, Hogdall, E V S, Poulsen, T S, Linnemann, D, Jensen, B V, Pfeiffer, P, Tarpgaard, L S, Brunner, N, Stenvang, J, Yilmaz, M & Nielsen, D L 2017, ' Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer ', BMC Cancer, vol. 17, 48 . https://doi.org/10.1186/s12885-016-3001-y